SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-13-003629
Filing Date
2013-06-26
Accepted
2013-06-26 16:15:53
Documents
12
Period of Report
2013-04-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT oxbt_10k.htm 10-K 2191774
2 oxbt_ex1069.htm EX-10.69 229843
3 oxbt_ex1070.htm EX-10.70 76987
4 CONSENT oxbt_ex231.htm EX-23.1 2698
5 CERTIFICATION oxbt_ex311.htm EX-31.1 11964
6 CERTIFICATION oxbt_ex321.htm EX-32.1 8371
  Complete submission text file 0001354488-13-003629.txt   8088645

Data Files

Seq Description Document Type Size
7 oxbt-20130430.xml EX-101.INS 1075952
8 oxbt-20130430.xsd EX-101.SCH 61527
9 oxbt-20130430_cal.xml EX-101.CAL 55592
10 oxbt-20130430_def.xml EX-101.DEF 95226
11 oxbt-20130430_lab.xml EX-101.LAB 364285
12 oxbt-20130430_pre.xml EX-101.PRE 270262
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
OXYGEN BIOTHERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 10-K | Act: 34 | File No.: 001-34600 | Film No.: 13934641
SIC: 8731 Services-Commercial Physical & Biological Research